表紙
市場調查報告書

實驗室自動化系統(LA)的全球市場:2019年∼2023年

Global Laboratory Automation Systems Market 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 301119
出版日期 內容資訊 英文 119 Pages
訂單完成後即時交付
價格
實驗室自動化系統(LA)的全球市場:2019年∼2023年 Global Laboratory Automation Systems Market 2019-2023
出版日期: 2019年01月24日內容資訊: 英文 119 Pages
簡介

供應商提供軟體作為其實驗室自動化系統的附加服務,以維持客戶忠誠度並確保品質結果。這些軟體服務配備了直觀性靈活的用戶界面,可以對資料樣本進行分析。這些軟體服務類似於手動電鍍程序。除了符合法規建議,如分析證書(COA)和合格證書(COC)。這些軟體服務可以根據最終用戶的需求進行更改。其功能多樣,可以在不同的平台上運行,如Windows XP、Windows Vista和Windows 7。此類軟體服務專為生命科學研究而設計,可增強藥物發現過程。另外,這些程式支持即時分析,並以幾種常見的文件格式保存和發送數據。具有內置的資料分析計算功能,有助於節省時間並產生高品質的結果,從而推動市場發展。Technavio的分析師預測,到2023年,實驗室自動化系統市場的年複合成長率將超過7%。

本報告提供全球實驗室自動化系統(LA)市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 報告的範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2018年)
  • 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各終端用戶

  • 市場區隔:各終端用戶
  • 各終端用戶比較:市場規模及預測(2018年∼2023年)
  • 製藥及生物科技企業
  • 臨床檢驗研究所
  • 學術機構及研究機關
  • 市場機會:各終端用戶

第7章 客戶形勢

第8章 地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2018年∼2023年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

第12章 業者情勢

  • 概要
  • 創造性破壞狀況

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Agilent Technologies
  • Danaher
  • PerkinElmer
  • QIAGEN
  • Thermo Fisher Scientific

第14章 附錄

  • 調查方法
  • 簡稱的清單

第15章 關於TECHNAVIO

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR30736

About this market

Vendors have started offering software as an additional service with their laboratory automation systems, to maintain customer loyalty and ensure quality results. These software services are equipped with an intuitive and flexible user interface, which enables the analysis of data sample. These software services resemble the manual plating procedure. Apart from being compliant with regulatory recommendations such as the Certificates of Analysis (COA) and the Certificates of Conformance (COC). These software services can be altered according to the needs of end-users. It is versatile and can run on different platforms such as Windows XP, Windows Vista: and Windows 7. Such software services have been designed specifically for life sciences research and enhance the drug discovery process. Additionally, these programs support real-time analysis and save and send the data in several common file formats. They have built-in calculations for data analysis and help save time and generate high-quality results, thereby driving the market. Technavio's analysts have predicted that the laboratory automation systems market will register a CAGR of over 7% by 2023.

Market Overview

Rising use of automated solutions in healthcare

Fully automated laboratory solutions can help save cost and generate accurate results. Automated solutions can also help save the time of healthcare professionals, as automation replaces manually intensive tasks: which allows researchers to devote more time to analysis and data interpretation. Automation solutions in healthcare, which include automated systems, software, and other services, also improve laboratory productivity, as they reduce the chances of human errors.

Lack of adoption of automated solutions by small-scale and medium-scale laboratories

Medium and small-scale laboratories handle a lower volume of samples as they are mostly established to address specific applications such as diagnosis and testing of biological samples. These laboratories lack adequate budgets. staff, or planning. Therefore, they do not prioritize automation. Moreover, small-and medium-scale laboratories are reluctant to procure laboratory automation systems due to lack of floor space.

For the detailed list of factors that will drive and challenge the growth of the laboratory automation systems market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be mildly fragmented and with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023
  • Clinical and reference laboratories - Market size and forecast 2018-2023
  • Academic institutes and research organizations - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Agilent Technologies
  • Danaher
  • PerkinElmer
  • QIAGEN
  • Thermo Fisher Scientific

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations

PART 15: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global healthcare market
  • Exhibit 02: Segments of global healthcare market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: End-user - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by end-user
  • Exhibit 19: Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Clinical and reference laboratories - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Clinical and reference laboratories - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Academic institutes and research organizations - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Academic institutes and research organizations - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Market opportunity by end-user
  • Exhibit 26: Customer landscape
  • Exhibit 27: Market share by geography 2018-2023 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Key leading countries
  • Exhibit 38: Market opportunity
  • Exhibit 39: Impact of drivers and challenges
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: Agilent Technologies - Vendor overview
  • Exhibit 46: Agilent Technologies - Business segments
  • Exhibit 47: Agilent Technologies - Organizational developments
  • Exhibit 48: Agilent Technologies - Geographic focus
  • Exhibit 49: Agilent Technologies - Segment focus
  • Exhibit 50: Agilent Technologies - Key offerings
  • Exhibit 51: Danaher - Vendor overview
  • Exhibit 52: Danaher - Business segments
  • Exhibit 53: Danaher - Organizational developments
  • Exhibit 54: Danaher - Geographic focus
  • Exhibit 55: Danaher - Segment focus
  • Exhibit 56: Danaher - Key offerings
  • Exhibit 57: PerkinElmer - Vendor overview
  • Exhibit 58: PerkinElmer - Business segments
  • Exhibit 59: PerkinElmer - Organizational developments
  • Exhibit 60: PerkinElmer - Geographic focus
  • Exhibit 61: PerkinElmer - Segment focus
  • Exhibit 62: PerkinElmer - Key offerings
  • Exhibit 63: QIAGEN - Vendor overview
  • Exhibit 64: QIAGEN - Business segments
  • Exhibit 65: QIAGEN - Organizational developments
  • Exhibit 66: QIAGEN - Geographic focus
  • Exhibit 67: QIAGEN - Segment focus
  • Exhibit 68: QIAGEN - Key offerings
  • Exhibit 69: Thermo Fisher Scientific - Vendor overview
  • Exhibit 70: Thermo Fisher Scientific - Business segments
  • Exhibit 71: Thermo Fisher Scientific - Organizational developments
  • Exhibit 72: Thermo Fisher Scientific - Geographic focus
  • Exhibit 73: Thermo Fisher Scientific - Segment focus
  • Exhibit 74: Thermo Fisher Scientific - Key offerings